Accessibility Menu
Invesco Exchange-Traded Fund Trust - Invesco Pharmaceuticals ETF logo

Invesco Exchange-Traded Fund Trust - Invesco Pharmaceuticals ETF(NYSEMKT) PJP

Current Price$118.03
Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2005)+919%
5 Year+54%
1 Year+45%
1 Month+6%
Invesco Exchange-Traded Fund Trust - Invesco Pharmaceuticals ETF last closing stock price
MetricPriceDate
Last closeUSD 117.912026-07-20
Invesco Exchange-Traded Fund Trust - Invesco Pharmaceuticals ETF stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.26%USD 117.602026-07-13
1 month+5.89%USD 111.362026-06-18
3 month+13.12%USD 104.232026-04-21
Year to date+13.42%USD 103.962025-12-31
1 year+45.07%USD 81.282025-07-18
3 year+56.22%USD 75.472023-07-21
5 year+53.93%USD 76.602021-07-21
Since inception+918.7%USD 11.572005-06-23

Invesco Exchange-Traded Fund Trust - Invesco Pharmaceuticals ETF Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$1.07

Beta (Volatility)

0.58 (Low)

Price

$118.03

Volume

47,333.34

Open

$117.60

Previous Close

$117.91

Daily Range

$117.60 - $119.25

52-Week Range

$80.63 - $122.69

Estimated Earnings Date

N/A

PJP News

ETFvsETF-Green.png

Will the Invesco Pharma ETF or iShares Global Healthcare Fund Be the Better Health Care Fund in 2026?

Brendan CoffeyJul 20, 2026
ETFvsETF-Red.png

PJP vs. IYH: Which Healthcare ETF Is the Better Buy?

Andy GouldJul 20, 2026
ETFvsETF-Purple.png

Invesco Pharmaceuticals ETF vs State Street Biotech ETF: Which Fund Is the Better Buy in 2026?

Brendan CoffeyJul 9, 2026
ETFvsETF-Blue.png

Invesco Pharmaceuticals ETF or First Trust Biotech Fund: Which Drug Maker-Focused Fund Should You Buy in 2026?

Brendan CoffeyJul 8, 2026
ETFvsETF-Purple.png

IHE vs. PJP: Which Pharmaceutical ETF Is the Better Buy for Investors?

Andy GouldJul 5, 2026
ETFvsETF-Blue.png

Which Pharmaceutical ETF Is Better, VanEck's PPH or Invesco's PJP?

Robert IzquierdoJul 4, 2026
ETFvsETF-Blue.png

State Street Health Care ETF Tops Invesco Pharma on Cost and Size

Erin KennedyJul 4, 2026
ETFvsETF-Purple.png

Invesco's RSPH vs. PJP: Which Health Care ETF Is the Better Fund For The GLP-1 Revolution?

Brendan CoffeyJun 15, 2026
Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Invesco Exchange-Traded Fund Trust - Invesco Pharmaceuticals ETF

The Invesco Pharmaceuticals ETF is designed to replicate the performance of the Dynamic Pharmaceutical Intellidex Index. This fund primarily invests in U.S. pharmaceutical companies, focusing on capital appreciation through a rigorous selection process.

Products and Services
  • Invests in common stocks of pharmaceutical companies
  • Tracks the Dynamic Pharmaceutical Intellidex Index
  • Undergoes quarterly adjustments for optimal performance
Growth Outlook
  • Achieved a 4-star rating from Morningstar among 164 funds
  • Earned 5 stars for three- and five-year performance periods
  • Consists of 30 leading U.S. pharmaceutical enterprises
Financial Highlights
  • Market capitalization of approximately $342.45 million
  • Dividend yield of 0.95% based on trailing twelve months
  • Stock price range between $78.77 and $114.31 over the year
The Invesco Pharmaceuticals ETF focuses on a well-defined sector, investing in companies engaged in the pharmaceutical industry. The fund's strategy emphasizes rigorous assessment criteria, ensuring that only the most promising stocks are included. The recent performance ratings from Morningstar highlight the fund's strong historical returns, particularly over the last five years. With a solid market capitalization and a competitive dividend yield, the fund presents an attractive option for investors interested in the pharmaceutical sector. The stock's price range indicates potential for growth, making it a noteworthy consideration for those looking to diversify their investment portfolios.
AI Generated • Jun 22, 2026

Industry

Capital Markets

Sector

Financials

Headquarters

Downers Grove, IL 60515, US

PJP Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.90%

Payout Ratio

N/A

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

3.64M

Volume

47.33K

Avg. Volume

30.42K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Invesco Exchange-Traded Fund Trust - Invesco Pharmaceuticals ETF Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PIOInvesco Global Water ETF
$43.96+0.21%
BRTRiShares Total Return Active ETF
$49.67-0.18%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$7.68+0.12%
MARAMara Holdings
$12.63+0.08%
UTZUtz Brands
$14.09+0.89%
AALAmerican Airlines Group
$15.35+0.01%

Questions About PJP

What is the current price of Invesco Exchange-Traded Fund Trust - Invesco Pharmaceuticals ETF?

Invesco Exchange-Traded Fund Trust - Invesco Pharmaceuticals ETF is trading at $118.85 per share.

What is the 52-week range for Invesco Exchange-Traded Fund Trust - Invesco Pharmaceuticals ETF?

Over the past 52 weeks, Invesco Exchange-Traded Fund Trust - Invesco Pharmaceuticals ETF has traded between $80.63 and $122.69.

How much debt does Invesco Exchange-Traded Fund Trust - Invesco Pharmaceuticals ETF have?

Invesco Exchange-Traded Fund Trust - Invesco Pharmaceuticals ETF total debt is unavailable.

How much cash does Invesco Exchange-Traded Fund Trust - Invesco Pharmaceuticals ETF have on hand?

Invesco Exchange-Traded Fund Trust - Invesco Pharmaceuticals ETF does not have cash on hand data available.

What is Invesco Exchange-Traded Fund Trust - Invesco Pharmaceuticals ETF’s dividend yield?

Invesco Exchange-Traded Fund Trust - Invesco Pharmaceuticals ETF currently has a dividend yield of 0.90%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services